300 bacterial isolates associated with post surgical wound infections were tested in vitro for their sensitivity/resistance pattern against 20 antibacterial agents. The study indicated that the bacteria in which clinically significant resistance has now, become a potential problem include Pseudomonas aeruginosa, Staphylococcus aureus, Escherichia coli, Proteus, Klebsiella, Staphylococcus epidermidis, Enterobacter and Citrobacter species. Among the tested drugs the percent resistance rate observed were tobramycin (9.75%), amikacin (10.03%), enoxacin (20.53%), ofloxacin (25.93%), ciprofloxacin (26.27%), gentamicin (29.03%), ceftrioxone (36%), aztreonam (41.07%), cefaclor (44.07%). The conclusion from the study can be drawn that tobramycin and amikacin (aminoglycosides) and enoxacin, ciprofloxacin and ofloxacin (Fluoroquinolones) are very effective agents for treating post surgical wound infections. However resistance to these agents is rapidly increasing.